How is sarcopenia distinguished from other conditions?

    Researchedby:
    Last Updated: October 25, 2023

    There are three main conditions that overlap with sarcopenia: frailty, malnutrition, and cachexia. Frailty is a state of increased vulnerability due to cumulative decline in multiple physiological systems[1] and involves adverse effects to physical, cognitive, and social dimensions.[2] Sarcopenia contributes to the physical aspect of frailty, but it differs from frailty because it only affects the musculoskeletal system, whereas frailty is a much broader condition.

    Both malnutrition and sarcopenia are characterized by low muscle mass, but sarcopenia also includes impaired muscle function. Additionally, reduced fat mass is typically present in malnutrition, but not sarcopenia.[3]

    Cachexia is described as severe weight loss and muscle wasting associated with conditions such as cancer, HIV/AIDS, or end-stage organ failure. Cachexia and sarcopenia may coexist, but the presence of the aforementioned conditions suggests that cachexia is more likely.[4] Unlike sarcopenia, cachexia is characterized by systemic inflammation, as indicated by low serum albumin and elevated C-reactive protein levels.[5] The diagnosis of cachexia also typically requires unintentional weight loss of at least 5% of body weight in the past six months.[5]

    References

    1. ^Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood KFrailty in elderly people.Lancet.(2013-Mar-02)
    2. ^Langlois F, Vu TT, Kergoat MJ, Chassé K, Dupuis G, Bherer LThe multiple dimensions of frailty: physical capacity, cognition, and quality of life.Int Psychogeriatr.(2012-Sep)
    3. ^Alfonso J Cruz-Jentoft, Gülistan Bahat, Jürgen Bauer, Yves Boirie, Olivier Bruyère, Tommy Cederholm, Cyrus Cooper, Francesco Landi, Yves Rolland, Avan Aihie Sayer, Stéphane M Schneider, Cornel C Sieber, Eva Topinkova, Maurits Vandewoude, Marjolein Visser, Mauro Zamboni, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2Sarcopenia: revised European consensus on definition and diagnosisAge Ageing.(2019 Jan 1)
    4. ^Andrew D. Ardeljan, Razvan HurezeanuSarcopenia
    5. ^Douglas E, McMillan DCTowards a simple objective framework for the investigation and treatment of cancer cachexia: the Glasgow Prognostic Score.Cancer Treat Rev.(2014-Jul)